Dr. Rick Bright predicts coronavirus vaccine will take longer than 12 to 18 months to develop

Dr. Rick Bright, the ousted federal official who was previously leading coronavirus vaccine development, told Congress on Thursday a COVID-19 vaccine may take longer to develop than 18 months.
Bright testified on Capitol Hill after filing a whistleblower complaint alleging his recent ouster was retaliatory, and he was asked when he thinks there could be a COVID-19 vaccine. Experts like Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, have cited a possible timeline of between 12 and 18 months. Bright, however, wasn't so sure.
"A lot of optimism is swirling around a 12 to 18 month timeframe, if everything goes perfectly," Bright said. "We've never seen everything go perfectly. ... I still think 12 to 18 months is an aggressive schedule, and I think it's going to take longer than that to do so."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Bright also expressed concern about rushing a vaccine and cutting out steps so that we don't have a "full assessment" of its safety. The 12 to 18 month timeline is from when a given manufacturer first started developing a vaccine rather than from right now, and it refers to how long until a vaccine can be used on an emergency basis rather than until it's approved by the FDA, Bright explained.
President Trump in recent weeks has expressed confidence there will be a coronavirus vaccine by the end of 2020. Testifying before Congress earlier this week, Fauci said it's "more likely than not" there will be a vaccine within the next one to two years, and he said earlier this month having a vaccine ready by January 2021 is potentially "doable," assuming "things fall in the right place." Brendan Morrow
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
6 grand homes in Boulder
Feature Featuring a mountain-facing balcony in Lower Chautauqua and a clover-shaped home in Flagstaff
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published